Shares of Teleflex Inc. slipped 4.57% to $132.75 Friday, on what proved to be an all-around great trading session for the ...

Teleflex's business units, including urology and acute care will come under NewCo, with interventional and surgical under ...

Teleflex, whose shares sank nearly 20% Thursday, will acquire most of Biotronik’s vascular intervention assets. Teleflex also ...

Truist lowered the firm’s price target on Teleflex (TFX) to $149 from $200 and keeps a Hold rating on the shares. The firm says the company’s ...

TFX benefits from a diversified product portfolio in the fourth quarter of 2024, with strength in the Surgical and ...

Teleflex (NYSE: TFX) announced today that it plans to separate its Urology, Acute Care and OEM businesses into a new publicly ...

Teleflex to separate into two companies by mid-2026 and acquire Biotronik's Vascular Intervention unit for €760 million. CFO ...

Learn more about whether LeMaitre Vascular, Inc. or Teleflex Incorporated is a better investment based on AAII's A+ Investor ...

Teleflex (TFX – Research Report) received a Hold rating and price target from Raymond James analyst Jayson Bedford today. The company’s ...

Teleflex has announced a plan to split its business into two separate independent companies—and it’s setting up one of its ...

Acquisition will further advance Teleflex’s Interventional portfolio with a differentiated global suite of coronary vascular ...

Teleflex Inc. closed 44.33% below its 52-week high of $249.91, which the company reached on September 27th.